Skip to main content
TipRanks
Go Ultimate75% OFF

Dayton Misfeldt Insider Profile

4 Followers

Dayton Misfeldt, former Interim Chief Executive Officer (Principal Executi, Director at Viracta Therapeutics, holds 30.71K shares in Viracta Therapeutics (Ticker: VIRX). Most recently, Dayton Misfeldt Bought 400,000 shares of Viracta Therapeutics on Oct 30, 2017 for an estimated value of $800.00K.

Dayton Misfeldt's Trading History

VIRX
Viracta Therapeutics
Oct 30, 2017―Informative Buy800.00K$307.08
VIRX
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 30, 2017Informative Buy$800.00K400,000$2.00-37.60%
Dec 21, 2015Informative Buy$1.47M1,750,000$0.84-30.90%
Dec 21, 2015Informative Sell$14.42K3,962$3.640.00%
Dec 21, 2015Uninformative Sell$2.19M1,656,620$3.46―
Aug 29, 2014Informative Sell$2.40M300,700$7.97+83.80%

You May Also Like

Dayton Misfeldt insider profile FAQ

What is the percentage of profitable transactions made by Dayton Misfeldt?
The percentage of profitable transactions made by Dayton Misfeldt is 40%.
What is the average return per transaction made by Dayton Misfeldt?
The average return per transaction made by Dayton Misfeldt is 19.10%.
What stocks does Dayton Misfeldt hold?
Dayton Misfeldt holds: VIRX stocks.
What was Dayton Misfeldt’s latest transaction?
Dayton Misfeldt’s latest transaction was an Informative Buy of $800.00K.
What was Dayton Misfeldt's most profitable transaction?
Dayton Misfeldt’s most profitable transaction was an Informative Sell of VIRX stock on August 29, 2014. The return on the trade was 83.80%.
What is Dayton Misfeldt's role in Viracta Therapeutics?
Dayton Misfeldt's role in Viracta Therapeutics is Interim Chief Executive Officer (Principal Executi, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.